Home Newsfeeds SVB Leerink Maintains Market Perform on WAVE Life Sciences, Raises Price Target to $7

SVB Leerink Maintains Market Perform on WAVE Life Sciences, Raises Price Target to $7

SVB Leerink analyst Mani Foroohar maintains WAVE Life Sciences (NASDAQ:WVE) with a Market Perform and raises the price target from $2 to $7.

byBenzinga Newsdesk

December 14, 2022

1 minute read

SVB Leerink analyst Mani Foroohar maintains WAVE Life Sciences (NASDAQ:WVE) with a Market Perform and raises the price target from $2 to $7.

FDA
News

‘Latest Polio Outbreak Reveals Rare Risk of Oral Vaccine’ -NBC New York Report

By Benzinga Newsdesk

August 22, 9:37 AM

https://www.nbcnewyork.com/news/national-international/us-polio-outbreak-linked-to-the-oral-vaccine-revealing-its-risks/3833258/?_osource=SocialFlowTwt_NYBrand

SNY

Dow Dips Over 300 Points; McDonald’s Beats Q1 Expectations

By Lisa Levin

April 25, 2:30 PM

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Tuesday. The Dow traded down 0.92% to 33,562.53 while the NASDAQ fell 1.75% to 11,826.47. The S&P 500, also fell, dropping, 1.40% to 4,079.31.

AGFY